To join a alzheimer disease clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.

What phases are alzheimer disease trials in France?

Active alzheimer disease trials in France span Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.

Browse More

All France Trials → Global alzheimer disease Trials → All Countries → All Trials →

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology

Active Trials in France (5)

Diagnostic and Prognostic Value of New Quick Tests of Action Slowing in Stroke and in Cognitive Neurodegenerative Disease

Safety of a Strategy Combining Etanercept Administration With Repeated Contrast Ultrasound in Patients With Alzheimer's Disease

OCT-Angiography and Adaptive Optics in Patients With Memory Impairment

Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease

Memory and Social Interactions

Frequently Asked Questions